HealthQuad raises US $ 162 million in second fund
The fund has already invested in seven companies including Medikabazaar, THB, Impact Guru, Stanplus, Ekincare, Qure.ai and HealthifyMe
The fund has already invested in seven companies including Medikabazaar, THB, Impact Guru, Stanplus, Ekincare, Qure.ai and HealthifyMe
Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre In conversation with Thomas C Thottathil, Editor, www.indianpharmapost.com identified key areas that the company is focusing on in its Mission 2025
The objective behind introducing this extraordinary digital campaign is to spread awareness among Gen X and Z for the need of breast self-examination
Madhavbaug has a pan-India presence with a vast network of 272 clinics and two hospitals
The R&D centre will endeavour to bring scientifically advanced biological, biotechnology products and novel drug delivery systems
A total of 8308 stores are open across India and medicines are priced at affordable rates
More than 90,000 patients utilise the services daily
The two startups will utilise the capital for business growth including strategic expansion, product development, R&D and technology investments
CLSA, a capital market and investment group organised an Investors’ Forum where five Indian pharma companies participated. Excerpts from the report
Between 30-40 per cent of Covid-19 patients are either obese or diabetic
Subscribe To Our Newsletter & Stay Updated